BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19157138)

  • 1. [Clinical analysis of hepatic veno-occlusive disease induced by Sedum aizoon].
    Wu GL; Yu GY; Chen J
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2402-4. PubMed ID: 19157138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic veno-occlusive disease induced by Gymura segetum: report of two cases.
    Dai HF; Gao Y; Yang M; Yu CH; Gu ZY; Chen WX
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):406-8. PubMed ID: 16911940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic veno-occlusive disease: report of two cases].
    Chen WX; Yang M; Yu CH; Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):394-5. PubMed ID: 15918986
    [No Abstract]   [Full Text] [Related]  

  • 4. Computed tomography findings of hepatic veno-occlusive disease caused by Sedum aizoon with histopathological correlation.
    Shao H; Chen HZ; Zhu JS; Ruan B; Zhang ZQ; Lin X; Gan MF
    Braz J Med Biol Res; 2015 Dec; 48(12):1145-50. PubMed ID: 26517336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
    Lin G; Wang JY; Li N; Li M; Gao H; Ji Y; Zhang F; Wang H; Zhou Y; Ye Y; Xu HX; Zheng J
    J Hepatol; 2011 Apr; 54(4):666-73. PubMed ID: 21146894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical condition evaluation of hepatic veno-occlusive disease induced by gynura segetum].
    Wu XJ; Yu MY; Yan YW
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):635-6. PubMed ID: 24163873
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic veno-occlusive disease induced by Chinese medicinal herbs.
    Mejías Manzano MLÁ; Giráldez Gallego Á; Serrano Jiménez M
    Rev Esp Enferm Dig; 2017 Nov; 109(11):804. PubMed ID: 29032695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations.
    Chen Z; Huo JR
    Neth J Med; 2010 Jun; 68(6):252-60. PubMed ID: 20558855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two new prenylated isoflavones from Sedum aizoon L.
    Li WL; Luo QY; Wu LQ
    Fitoterapia; 2011 Apr; 82(3):405-7. PubMed ID: 21112377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum.
    Chen Z; Huo JR; Yang L; Zhu HY
    J Gastroenterol Hepatol; 2011 Jun; 26(6):1016-21. PubMed ID: 21251065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphological and histological studies of herba sedum aizoon].
    Cheng Y; Liang D; Zhan Y
    Zhong Yao Cai; 2001 May; 24(5):330-2. PubMed ID: 12587206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Veno-occlusive disease of the liver induced by low-dose cyclophosphamide.
    Modzelewski JR; Daeschner C; Joshi VV; Mullick FG; Ishak KG
    Mod Pathol; 1994 Dec; 7(9):967-72. PubMed ID: 7892168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dactinomycin-induced veno-occlusive disease in rats. The hepatoprotective action of amifostine. Evaluation in a light and electron microscope.
    Borowska H; Arciszewska E; Czauderna P; Sawicki B
    Folia Morphol (Warsz); 2004 Feb; 63(1):91-3. PubMed ID: 15039909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine-induced hepatic veno-occlusive disease in a renal transplant recipient: histological regression following azathioprine withdrawal.
    Kohli HS; Jain D; Sud K; Jha V; Gupta KL; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1671-2. PubMed ID: 8856241
    [No Abstract]   [Full Text] [Related]  

  • 15. [Veno-occlusive disease of the liver].
    Rybicka M; Krysiak R; Okopień B
    Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose methylprednisolone treatment of hepatic veno-occlusive disease in a child with Wilms tumor.
    Akyüz C; CaClar K; Emir S; Büyükpamukçu M
    Pediatr Hematol Oncol; 2003 Jun; 20(4):345-9. PubMed ID: 12746168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and managements of seventeen patients with hepatic veno-occlusive disease].
    Sun YL; Ma XX; Xu PQ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):523-6. PubMed ID: 20678444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.
    Gao H; Li N; Wang JY; Zhang SC; Lin G
    J Dig Dis; 2012 Jan; 13(1):33-9. PubMed ID: 22188914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic veno-occlusive disease associated with immunosuppressive cyclophosphamide dosing and roxithromycin.
    Beltinger J; Haschke M; Kaufmann P; Michot M; Terracciano L; Krähenbühl S
    Ann Pharmacother; 2006 Apr; 40(4):767-70. PubMed ID: 16595573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
    Boula AM; Mantadakis E; Xilouri IM; Christoforidou AV; Foudoulakis AM; Samonis G
    Am J Hematol; 2005 Jul; 79(3):216-9. PubMed ID: 15981233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.